Plexium
- Biotech or pharma, therapeutic R&D
- Medical device or technology
San Diego based, clinical stage, targeted protein degradation (TPD) company discovering the next generation of monovalent degrader drug candidates, including molecular glues and direct degraders.
Our ultra–High Throughput (uHT) cell-based platform enables drug discovery via screening large compound libraries and simultaneously integrating data sets from a variety of readouts: protein degradation/inhibition, phenotypic and transcriptomic responses